Expression of the prolyl isomerase Pin1 is a useful indicator of sensitivity of chemoradiotherapy in advanced esophageal squamous cell carcinoma

Oncology Reports

Volumn 21, Issue 4, 2009, Pages 853-859

  Fukuchi, Minoru ^a   Fukai, Yasuyuki ^a   Sohda, Makoto ^a   Miyazaki, Tatsuya ^a   Nakajima, Masanobu ^a   Inose, Takanori ^a   Tanaka, Naritaka ^a   Tsukada, Katsuhiko ^a   Kato, Hiroyuki ^a   Kuwano, Hiroyuki ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemoradiotherapy; CyclinD1; Esophageal squamous cell carcinoma; p53; Pin1

Indexed keywords

CISPLATIN; CYCLIN D1; FLUOROURACIL; NEDAPLATIN; PEPTIDYLPROLYL ISOMERASE PIN1; PROTEIN P53; CCND1 PROTEIN, HUMAN; NIMA INTERACTING PEPTIDYLPROLYL ISOMERASE; NIMA-INTERACTING PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL EFFECTIVENESS; CLINICAL INDICATOR; CONTINUOUS INFUSION; DRUG SENSITIVITY; ENDOSCOPIC BIOPSY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TREATMENT INDICATION; TREATMENT RESPONSE; ENZYMOLOGY; ESOPHAGUS TUMOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; CYCLIN D1; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PEPTIDYLPROLYL ISOMERASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 67449091153     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000294     Document Type: Article

References (38)

1. Sugimachi K, Watanabe M, Sadanaga N, Ikebe M, Kitamura K, Mori M and Kuwano H: Recent advances in the diagnosis and surgical treatment of patients with carcinoma of the esophagus. J Am Coll Surg 178: 363-368, 1994.
2. Byfield JE: Combined modality infusional chemotherapy with radiation. In: Cancer Chemotherapy by Infusion. Lokich JJ (ed). 2nd edition, Percepta Press, Chicago, IL, pp521-551, 1990.
3. Coia LR: Chemoradiation as primary management of esophageal cancer. Semin Oncol 21: 483-492, 1994.
4. Forastiere AA, Orringer MB, Perez-Tamayo C, Urba SG and Zahurak M: Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol 11: 1118-1123, 1993.
5. Ohtsu A, Yoshida S, Boku N, Fujii T, Miyata Y, Hosokawa K, Koba I, Shimizu W and Ogino T: Concurrent chemotherapy and radiation therapy for locally advanced carcinoma of the esophagus. Jpn J Clin Oncol 25: 261-266, 1995.
6. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849, 1993.
7. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852, 1993.
8. Mendonca MS, Rodriguez A and Alpen EL: Quiescence in 9L cells and correlation with radiosensitivity and PLD repair. Radiat Res 117: 433-447, 1989.
9. Masunaga S, Ono K and Abe M: A method for the selective measurement of the radiosensitivity of quiescent cells in solid tumors - combination of immunofluorescence staining to BrdU and micronucleus assay. Radiat Res 125: 243-247, 1991.
10. Okuno Y, Nishimura Y, Kashu I, Ono K and Hiraoka M: Prognostic values of proliferating cell nuclear antigen (PCNA) and Ki-67 for radiotherapy of oesophageal squamous cell carcinomas. Br J Cancer 80: 387-395, 1999.
11. Shamma A, Doki Y, Shiozaki H, Tsujinaka T, Inoue M, Yano M, Kimura Y, Yamamoto M and Monden M: Effect of cyclin D1 and associated proteins on proliferation of esophageal squamous cell carcinoma. Int J Oncol 13: 455-460, 1998.
12. Blume-Jensen P and Hunter T: Oncogenic kinase signalling. Nature 411: 355-365, 2001.
13. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000.
14. Lu KP, Hanes SD and Hunter T: A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380: 544-547, 1996.
15. Lu KP, Liou YC and Zhou XZ: Pinning down proline-directed phosphorylation signaling. Trends Cell Biol 12: 164-172, 2002.
16. Yaffe MB, Schutkowski M, Shen M, Zhou XZ, Stukenberg PT, Rahfeld JU, Xu J, Kuang J, Kirschner MW, Fischer G, Cantley LC and Lu KP: Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 278: 1957-1960, 1997.
17. Ranganathan R, Lu KP, Hunter T and Noel JP: Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent. Cell 89: 875-886, 1997.
18. Wulf GM, Ryo A, Wulf GG, Lee SW, Niu T, Petkova V and Lu KP: Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J 20: 3459-3472, 2001.
19. Ryo A, Nakamura M, Wulf G, Liou YC and Lu KP: Pin1 regulates turnover and subcellular localization of β-catenin by inhibiting its interaction with APC. Nat Cell Biol 3: 793-801, 2001.
20. Zheng H, You H, Zhou XZ, Murray SA, Uchida T, Wulf G, Gu L, Tang X, Lu KP and Xiao ZX: The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature 419: 849-853, 2002.
21. Zacchi P, Gostissa M, Uchida T, Salvagno C, Avolio F, Volinia S, Ronai Z, Blandino G, Schneider C and Del Sal G: The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 419: 853-857, 2002.
22. Miyashita H, Mori S, Motegi K, Fukumoto M and Uchida T: Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression. Oncol Rep 10: 455-461, 2003.
23. Miyashita H, Uchida T, Mori S, Echigo S and Motegi K: Expression status of Pin1 and cyclins in oral squamous cell carcinoma: Pin1 correlates with Cyclin D1 mRNA expression and clinical significance of cyclins. Oncol Rep 10: 1045-1048, 2003.
24. Ayala G, Wang D, Wulf G, Frolov A, Li R, Sowadski J, Wheeler TM, Lu KP and Bao L: The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res 63: 6244-6251, 2003.
25. Fukuchi M, Fukai Y, Kimura H, Sohda M, Miyazaki T, Nakajima M, Masuda N, Tsukada K, Kato H and Kuwano H: Prolyl isomerase Pin1 expression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclinD1 expression. Int J Oncol 29: 329-334, 2006.
26. Sobin LH and Wittekind CH: International Union Against Cancer (UICC). TNM Classification of Malignant Tumors. 6th edition, Wiley-Liss, New York, pp10-12, 2002.
27. The Japanese Esophageal Society: Guide Lines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus. 10th edition, Kanehara, Tokyo, 2007.
28. Sohda M, Ishikawa H, Masuda N, Kato H, Miyazaki T, Nakajima M, Fukuchi M, Manda R, Fukai Y, Sakurai H and Kuwano H: Pretreatment evaluation of combined HIF-1alpha, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer. Int J Cancer 110: 838-844, 2004.
29. Samejima R, Kitajima Y, Yunotani S and Miyazaki K: Cyclin D1 is a possible predictor of sensitivity to chemoradiotherapy for esophageal squamous cell carcinoma. Anticancer Res 19: 5515-5521, 1999.
30. Shimada Y, Watanabe G, Yamasaki S, Maeda M, Kawabe A, Kaganoi JI, Itami A, Fukumoto M, Kanda Y and Imamura M: Histological response of cisplatin predicts patients' survival in oesophageal cancer and p53 protein accumulation in pretreatment biopsy is associated with cisplatin sensitivity. Eur J Cancer 36: 987-993, 2000.
31. Miyata H, Doki Y, Yamamoto H, Kishi K, Takemoto H, Fujiwara Y, Yasuda T, Yano M, Inoue M, Shiozaki H, Weinstein IB and Monden M: Overexpression of CDC25B overrides radiation-induced G2-M arrest and results in increased apoptosis in esophageal cancer cells. Cancer Res 61: 3188-3193, 2001.
32. Hironaka S, Hasebe T, Kamijo T, Ohtsu A, Boku N, Yoshida S, Saitoh H and Ochiai A: Biopsy specimen microvessel density is a useful prognostic marker in patients with T(2-4)M(0) esophageal cancer treated with chemoradiotherapy. Clin Cancer Res 8: 124-130, 2002.
33. Takeuchi H, Ozawa S, Ando N, Kitagawa Y, Ueda M and Kitajima M: Cell-cycle regulators and the Ki-67 labeling index can predict the response to chemoradiotherapy and the survival of patients with locally advanced squamous cell carcinoma of the esophagus. Ann Surg Oncol 10: 792-800, 2003.
34. Doki Y, Imoto M, Han EK, Sgambato A and Weinstein IB: Increased expression of the P27KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1. Carcinogenesis 18: 1139-1148, 1997.
35. Levine AJ, Momand J and Finlay CA: The p53 tumour suppressor gene. Nature 351: 453-456, 1991.
36. Zhou XZ, Kops O, Werner A, Lu PJ, Shen M, Stoller G, Kullertz G, Stark M, Fischer G and Lu KP: Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol Cell 6: 873-883, 2000.
37. Shen M, Stukenberg PT, Kirschner MW and Lu KP: The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. Genes Dev 12: 706-720, 1998.
38. Winkler KE, Swenson KI, Kornbluth S and Means AR: Requirement of the prolyl isomerase Pin1 for the replication checkpoint. Science 287: 1644-1647, 2000.